- Home
- FENG vs KZR Comparison
FENG vs KZR Comparison
Compare FENG & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENG
- KZR
- Stock Information
- Founded
- FENG 1998
- KZR 2015
- Country
- FENG China
- KZR United States
- Employees
- FENG N/A
- KZR N/A
- Industry
- FENG Broadcasting
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- FENG Industrials
- KZR Health Care
- Exchange
- FENG Nasdaq
- KZR Nasdaq
- Market Cap
- FENG 32.7M
- KZR 29.7M
- IPO Year
- FENG 2011
- KZR 2018
- Fundamental
- Price
- FENG $2.23
- KZR $6.18
- Analyst Decision
- FENG
- KZR Hold
- Analyst Count
- FENG 0
- KZR 4
- Target Price
- FENG N/A
- KZR $6.00
- AVG Volume (30 Days)
- FENG 5.2K
- KZR 58.7K
- Earning Date
- FENG 11-12-2025
- KZR 11-12-2025
- Dividend Yield
- FENG N/A
- KZR N/A
- EPS Growth
- FENG N/A
- KZR N/A
- EPS
- FENG N/A
- KZR N/A
- Revenue
- FENG $106,947,410.00
- KZR N/A
- Revenue This Year
- FENG N/A
- KZR N/A
- Revenue Next Year
- FENG N/A
- KZR N/A
- P/E Ratio
- FENG N/A
- KZR N/A
- Revenue Growth
- FENG 9.17
- KZR N/A
- 52 Week Low
- FENG $1.28
- KZR $3.53
- 52 Week High
- FENG $3.65
- KZR $7.65
- Technical
- Relative Strength Index (RSI)
- FENG 47.95
- KZR 68.78
- Support Level
- FENG $2.05
- KZR $6.11
- Resistance Level
- FENG $2.22
- KZR $6.29
- Average True Range (ATR)
- FENG 0.10
- KZR 0.14
- MACD
- FENG 0.00
- KZR -0.07
- Stochastic Oscillator
- FENG 63.79
- KZR 64.06
About FENG Phoenix New Media Limited
Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives revenue from China.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.